Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | RBA | CTAS |
|---|---|---|
| Price | $80.10 | $195.75 |
| Change today | ▼ 1.59% | ▲ 0.35% |
| Market cap | $14.83B | $78.21B |
| Return, 3 months | -28.9% | +12.6% |
| Return, year to date | -21.4% | +4.9% |
| Return, 1 year | -24.5% | -2.9% |
| P/E (TTM) | 34.5 | 38.6 |
| P/B | 2.7 | 15.0 |
| P/E percentile vs own 5y | 21st | 44th |
| Dividend yield | 1.55% | 0.96% |
| Revenue growth (YoY, latest qtr) | +11.1% | +8.9% |
| Net profit growth (YoY) | +30.9% | +14.0% |
| Gross margin | 45.6% | 50.7% |
| Operating margin | 16.4% | 23.3% |
| Net margin | 9.0% | 17.7% |
| Return on equity | 7.9% | 40.6% |
| Analyst target vs. price | +66.3% | +13.0% |
| Analyst buy share | 100% | 75% |
| RSI (14) | 37 | 43 |
| 30-day volatility | 23.2% | 15.1% |
| Max drawdown, 1 year | -31.9% | -20.0% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
